PIN53 Cost-Effectiveness Analysis of Pegylated Interferon Alpha-2A Versus Pegylated Interferon Alpha-2B in the Treatment of Chronic Hepatitis C Patients in Poland

Interferon Alpha 2B ◽

Effectiveness Analysis ◽

P279 Reduction of hepatocellular carcinoma recurrence by pegylated interferon alpha-2b plus ribavirin treatment for chronic hepatitis C patients

International Journal of Antimicrobial Agents ◽

10.1016/s0924-8579(13)70520-x ◽

2013 ◽

Vol 42 ◽

pp. S130

Author(s):

N. Furusyo ◽

M. Murata ◽

E. Ogawa ◽

H. Nomura ◽

J. Hayashi

Keyword(s):

Hepatocellular Carcinoma ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Interferon Alpha ◽

Pegylated Interferon ◽

Interferon Alpha 2B ◽

Hepatocellular Carcinoma Recurrence ◽

An early prognosis for the treatment of Chronic Hepatitis C patients with Pegylated Interferon-.ALPHA.2b plus Ribavirin-Monitoring analysis by the serum HCV core antigen values-

Kanzo ◽

10.2957/kanzo.47.355 ◽

2006 ◽

Vol 47 (7) ◽

pp. 355-356

Author(s):

Tatsuya Fujino ◽

Kazuto Goto ◽

Eiichiro Arimura ◽

Yumiko Sakiyama ◽

Ryosuke Takemoto ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Interferon Alpha ◽

Pegylated Interferon ◽

Core Antigen ◽

Interferon Alpha 2B ◽

Hcv Core Antigen ◽

Zinc Supplementation Prevents the Increase of Transaminase in Chronic Hepatitis C Patients during Combination Therapy with Pegylated Interferon .ALPHA.-2b and Ribavirin

Journal of Nutritional Science and Vitaminology ◽

10.3177/jnsv.53.213 ◽

2007 ◽

Vol 53 (3) ◽

pp. 213-218 ◽

Cited By ~ 28

Author(s):

Yasuko MURAKAMI ◽

Tomoko KOYABU ◽

Aiko KAWASHIMA ◽

Naoko KAKIBUCHI ◽

Takayo KAWAKAMI ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Interferon Alpha ◽

Zinc Supplementation ◽

Pegylated Interferon ◽

Interferon Alpha 2B ◽

An inadequate dose of ribavirin is related to virological relapse by chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin

Journal of Infection and Chemotherapy ◽

10.1007/s10156-012-0396-5 ◽

2012 ◽

Vol 18 (5) ◽

pp. 689-697 ◽

Cited By ~ 4

Author(s):

Eiichi Ogawa ◽

Norihiro Furusyo ◽

Jun Hayashi ◽

Eiji Kajiwara ◽

Kazuhiro Takahashi ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Interferon Alpha ◽

Pegylated Interferon ◽

Interferon Alpha 2B ◽

Virological Relapse ◽

The longitudinal quantitative assessment by transient elastography of chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin

Antiviral Research ◽

10.1016/j.antiviral.2009.04.002 ◽

2009 ◽

Vol 83 (2) ◽

pp. 127-134 ◽

Cited By ~ 91

Author(s):

Eiichi Ogawa ◽

Norihiro Furusyo ◽

Kazuhiro Toyoda ◽

Hiroaki Takeoka ◽

Shinji Maeda ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Interferon Alpha ◽

Quantitative Assessment ◽

Transient Elastography ◽

Pegylated Interferon ◽

Interferon Alpha 2B ◽

Cost effectiveness of pegylated interferon alpha 2b and ribavirin combination in chronic hepatitis C

Gut ◽

10.1136/gut.52.10.1532 ◽

2003 ◽

Vol 52 (10) ◽

pp. 1532-1532 ◽

Cited By ~ 5

Author(s):

T Poynard

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Interferon Alpha ◽

Pegylated Interferon ◽

Interferon Alpha 2B

Pegylated interferon alpha 2b for chronic hepatitis C

10.1002/14651858.cd007608.pub2 ◽

2009 ◽

Author(s):

Tahany Awad ◽

Kristian Thorlund ◽

Goran Hauser ◽

Mahasen Mabrouk ◽

Davor Stimac ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Interferon Alpha ◽

Pegylated Interferon ◽

Interferon Alpha 2B

Safety and efficacy of an escalating dose regimen of pegylated interferon alpha-2b in the treatment of haemodialysis patients with chronic hepatitis C

Journal of Viral Hepatitis ◽

10.1111/j.1365-2893.2009.01191.x ◽

2009 ◽

Vol 17 (6) ◽

pp. 410-418 ◽

Cited By ~ 9

Author(s):

S. S. Tan ◽

M. R. Abu Hassan ◽

A. Abdullah ◽

B. P. Ooi ◽

T. Korompis ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Interferon Alpha ◽

Dose Regimen ◽

Pegylated Interferon ◽

Safety And Efficacy ◽

Interferon Alpha 2B

766 A PANEL OF GENE EXPRESSION BIOMARKERS PREDICTING SUSTAINED VIROLOGIC RESPONSE (SVR) IN CHRONIC HEPATITIS C PATIENTS (CH-C) TREATED WITH PEGYLATED INTERFERON ALPHA AND RIBAVIRIN

Journal of Hepatology ◽

10.1016/s0168-8278(08)60768-0 ◽

2008 ◽

Vol 48 ◽

pp. S286

Author(s):

Z.M. Younossi ◽

A. Baranova ◽

M. Stepanova ◽

A. Afendy ◽

A. Wheeler ◽

...

Keyword(s):

Gene Expression ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Interferon Alpha ◽

Sustained Virologic Response ◽

Pegylated Interferon ◽

Virologic Response ◽

Serum procalcitonin levels in chronic hepatitis C patients under pegylated interferon-alpha plus ribavirin treatment

Journal of Clinical Virology ◽

10.1016/j.jcv.2006.08.014 ◽

2006 ◽

Vol 37 (4) ◽

pp. 329-331 ◽

Cited By ~ 2

Author(s):

Ioannis S. Elefsiniotis ◽

Aikaterini Petrocheilou ◽

Nikolaos Scarmeas ◽

Ioannis Ketikoglou ◽

Konstantinos D. Pantazis ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Interferon Alpha ◽

Pegylated Interferon ◽